Wong ECL, Hasan B, Dulai PS, Marshall JK, et al. End of induction patient reported outcomes predict clinical remission and endoscopic improvement with vedolizumab and adalimumab in ulcerative colitis. Scand J Gastroenterol 2022 Jul 30:1-8. doi: 10.1080/00365521.2022.2105169.
PMID: 35909369